[{"Assets_0_Q2_USD":185242000.0,"CommonStockSharesOutstanding_0_Q2_shares":22593162.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-60544000.0,"NetIncomeLoss_2_Q2_USD":-83878000.0,"NetIncomeLoss_1_Q2_USD":-43337000.0,"StockholdersEquity_0_Q2_USD":154107000.0,"Ticker":"ESPR","CIK":"1434868","name":"ESPERION THERAPEUTICS, INC.","OfficialName":"Esperion Therapeutics Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"302940173.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170808"}]